CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Black Diamond Therapeutics - CapyFin

Black Diamond Therapeutics

BDTX · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 3 months ago

Previous year: -$0.35

Weighted average common shares outstanding - diluted

Previous year: 51.81M

Research and development expenses

Previous year: $13.5M

General and administrative expenses

Previous year: $6.7M

Loading...

Key Statistics

Market Cap

$142M

P/E Ratio

27.18

Sector

N/A

Industry

N/A

52-Week High

$4.86

52-Week Low

$1.23

Weighted average common shares outstanding - diluted

57.67M

Research and development expenses

$10.5M

General and administrative expenses

$4.96M

Total operating expenses

$15.5M

Interest income

$595K

Black Diamond Therapeutics

Unlock previous datapoints

Black Diamond Therapeutics

Unlock previous datapoints

Black Diamond Therapeutics Revenue by Segment

Revenue by Segment

License Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...